Changeflow GovPing Healthcare Calibration-free pulse oximetry
Routine Notice Added Final

Calibration-free pulse oximetry

Favicon for changeflow.com ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B)
Published March 31st, 2026
Detected March 31st, 2026
Email

Summary

The USPTO granted Patent US12588841B2 to Viavi Solutions Inc. on March 31, 2026, covering calibration-free pulse oximetry devices and methods. The patent (20 claims) describes devices and methods for calculating arterial oxygen saturation using photoplethysmography (PPG) data analysis without requiring traditional calibration. Inventors: Lan Sun, Chang Meng Hsiung, Babs Soller.

What changed

The USPTO granted Patent US12588841B2 to Viavi Solutions Inc. on March 31, 2026, for calibration-free pulse oximetry technology. The patent covers devices that identify peak and trough timestamps from PPG data, generate absorption spectra, and calculate arterial oxygen saturation by fitting an arterial blood spectrum model to measured data. The patent contains 20 claims and names Lan Sun, Chang Meng Hsiung, and Babs Soller as inventors.

This is a routine patent grant creating no new regulatory obligations. Medical device manufacturers and healthcare technology companies developing pulse oximetry products should review the patent claims to assess potential infringement risks andFreedom-to-operate implications for competing or complementary products.

Source document (simplified)

← USPTO Patent Grants

Calibration-free pulse oximetry

Grant US12588841B2 Kind: B2 Mar 31, 2026

Assignee

VIAVI SOLUTIONS INC.

Inventors

Lan Sun, Chang Meng Hsiung, Babs Soller

Abstract

A device may identify a peak timestamp and a trough timestamp based on a first principal component of photoplethysmography (PPG) data associated with a plurality of wavelength channels. The device may generate a peak absorption spectrum based on the peak timestamp and the PPG data, and may generate a trough absorption spectrum based on the trough timestamp and the PPG data. The device may determine a measured arterial blood spectrum based on the peak absorption spectrum and the trough absorption spectrum. The device may fit the arterial blood spectrum model to the measured arterial blood spectrum to determine a set of values, each value in the set of values corresponding to a variable in a set of variables. The device may calculate an arterial oxygen saturation value based on one or more values of the set of values.

CPC Classifications

A61B 5/14552 A61B 5/02427

Filing Date

2022-04-29

Application No.

17661306

Claims

20

View original document →

Named provisions

Calibration-free pulse oximetry PPG data analysis Arterial oxygen saturation calculation

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12588841B2

Who this affects

Applies to
Medical device makers Healthcare providers Technology companies
Industry sector
3345 Medical Device Manufacturing 5112 Software & Technology
Activity scope
Patent
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.